Neurocrine Bioscience buy JPMorgan Chase & Co.
Start price
23.02.24
/
50%
€124.00
Target price
23.02.25
€136.69
Performance (%)
1.33%
Price
19:19
€125.65
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ shows slight gains of 1.33%. This prediction currently runs until 23.02.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | -4.178% | -4.178% |
iShares Core DAX® | 2.749% | 4.620% |
iShares Nasdaq 100 | 0.470% | -0.331% |
iShares Nikkei 225® | -2.930% | -5.556% |
iShares S&P 500 | 0.679% | 0.631% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target lowered by analysts at JPMorgan Chase & Co. from $154.00 to $148.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€128.85
20.03.24
20.03.24
€145.64
20.03.25
20.03.25
-2.79%
19:19
19:19
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.25
13.09.23
13.09.23
€124.83
13.09.24
13.09.24
16.78%
19:19
19:19